_field-notes-ep-19-124-slowing-down-progression-of-ckd-sglt2-inhibitors-with-dr-robert-kossmann-preview-1.jpg "Field Notes Ep. 19 | Slowing Down Progression of CKD - SGLT2 Inhibitors with Dr. Robert Kossmann from sgkt2 Video Screenshot Preview 1")
Gallery_field-notes-ep-19-124-slowing-down-progression-of-ckd-sglt2-inhibitors-with-dr-robert-kossmann-preview-3.jpg "Field Notes Ep. 19 | Slowing Down Progression of CKD - SGLT2 Inhibitors with Dr. Robert Kossmann from sgkt2 Video Screenshot Preview 3")
Gallery_field-notes-ep-19-124-slowing-down-progression-of-ckd-sglt2-inhibitors-with-dr-robert-kossmann-preview-hqdefault.jpg "Field Notes Ep. 19 | Slowing Down Progression of CKD - SGLT2 Inhibitors with Dr. Robert Kossmann from sgkt2 Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 15 minutes 35 seconds
👁 View: 896 times
Play Audio:👁 View: 896 times
Description:
Fresenius Medical Care North America
Fresenius Medical Care North America
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_when-should-we-use-sglt2-inhibitors.webp "The France Foundation")
_sglt2-inhibitors-in-chronic-kidney-disease.webp "Harvard Medical School Continuing Education")
_choosing-sglt2-inhibitors-vs-glp-1-receptor-agonists.webp "Harvard Medical School Continuing Education")
_sglt2-inhibitors-mechanism-of-action.webp "Nonstop Neuron")
_field-notes-ep-19-124-slowing-down-progression-of-ckd-sglt2-inhibitors-with-dr-robert-kossmann.webp "Fresenius Medical Care North America")
⏲ 15 minutes 35 seconds 👁 896
_sglt2-inhibitors-are-associated-with-reduced-cv-disease-in-type-2-diabetes.webp "Mayo Proceedings")
⏲ 5 minutes 7 seconds 👁 171
_introduction-to-sglt2-inhibition.webp "Boehringer Ingelheim")
_sglt2-inhibitors-in-heart-failure-new-analyses-and-recent-updates.webp "Cátedra USC Semergen")
⏲ 1 hour 5 minutes 21 seconds 👁 1.6K
_when-should-we-use-sglt2-inhibitors.jpg)
_sglt2-inhibitors-in-chronic-kidney-disease.jpg)
_choosing-sglt2-inhibitors-vs-glp-1-receptor-agonists.jpg)
_sglt2-inhibitors-mechanism-of-action.jpg)
_field-notes-ep-19-124-slowing-down-progression-of-ckd-sglt2-inhibitors-with-dr-robert-kossmann.jpg)
_sglt2-inhibitors-are-associated-with-reduced-cv-disease-in-type-2-diabetes.jpg)
_introduction-to-sglt2-inhibition.jpg)
_sglt2-inhibitors-in-heart-failure-new-analyses-and-recent-updates.jpg)
![[+]](/images/menu.gif){kind=small}